Completed

Neuropsychological Evaluation of Psychiatric and Neurological Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Anxiety Disorder
+2

+ Head Injury
+ Mood Disorder
Until 95 Years
How is the trial designed

Other

Observational
Study Start: October 1983

Summary

Principal SponsorNational Institute of Mental Health (NIMH)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner
Study start date: October 18, 1983Actual date on which the first participant was enrolled.

This study will allow researchers to use various types of tests to evaluate cognitive and sensory functions. These tests, referred to as "batteries" will evaluate attention, executive functions, general intellectual functioning, language, memory, motor functions, orientation, personality, selected sensory and perceptual functions, vigilance (alertness), and visual-spatial functions. Children and adult patient will receive different test batteries. The goals of this research study are to; 1. Create descriptions based on the performance of each patient on the test batteries. Then use this information to relate patient behavior to their neurophysiological, neuroradiological, and biochemical descriptions. 2. Define subgroups of patients based on their neurobehavior in order to decrease the variability of psychiatric diagnoses, treatments, and prognoses. Neuropsychological tests are used to provide an assessment of cognitive functions in patients with idiopathic generalized epileptic (IGE) disorders and their first-degree relatives. The battery comprises tests designed to tap attention, memory, selected sensory and perceptual functions, vigilance, and visual-spatial functions. Modified batteries have been developed for the assessment of children ages 5-8, and children ages 8-16. The data provided by these batteries are compared with genetic profiles of the same participants that have been ascertained from blood samples analyzed by colleagues at the Mount Sinai School of Medicine/Columbia University in New York City.

Official TitleNeuropsychological Evaluation of Psychiatric and Neurological Patients 
Principal SponsorNational Institute of Mental Health (NIMH)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
4300 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Until 95 YearsRange of ages for which participants are eligible to join.
Healthy volunteers allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Anxiety Disorder
Head Injury
Mood Disorder
Schizophrenia
Seizures
Criteria

* INCLUSION CRITERIA: Patients. Normal volunteers. EXCLUSION CRITERIA: Subjects over 95 years of age. Subjects with a history of alcohol or drug abuse, psychopathology, or central nervous system pathology, other than that which defines group membership, may be excluded.



Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 7 locations
Suspended
Childrens National Medical CenterWashington, D.C., United StatesSee the location
Suspended
National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, United States
Suspended
Henry Ford Health SystemsDetroit, United States
Suspended
Mt. Sinai Medical CenterNew York, United States

Completed7 Study Centers